Year archive

Cloudbreak Pharma Inc. — 2026 filings

All 30 regulatory filings released by Cloudbreak Pharma Inc. (2592) in 2026, sourced directly from the official regulator.

30 Filings

2026 Period

2026 filings (30)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-04	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE IN RELATION TO INVESTIGATIONAL NEW DRUG APPLICATION FOR CBT-199 COMPLETED SAFETY REVIEW BY FOOD AND DRUG ADMINISTRATION Regulatory Filings	2026-04-30	English
UPDATE ANNOUNCEMENT Regulatory Filings	2026-04-22	English
Next Day Disclosure Return Share Issue/Capital Change	2026-04-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-01	English
Environmental, Social and Governance Report 2025 Regulatory Filings	2026-03-31	English
ANNUAL REPORT 2025 Regulatory Filings	2026-03-31	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 Annual Report FY 2025	2026-03-30	English
TEMPORARY DEVIATION FROM THE USE OF PROCEEDS AND NOTIFIABLE TRANSACTION Regulatory Filings	2026-03-30	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE IN RELATION TO INVESTIGATIONAL NEW DRUG APPLICATION FOR CBT-009 Regulatory Filings	2026-03-19	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-02	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-04	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-02-04	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Share Issue/Capital Change	2026-02-04	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Share Issue/Capital Change	2026-02-04	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Share Issue/Capital Change	2026-02-04	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2026-02-04	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2026-02-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-02	English
INSIDE INFORMATION ANNOUNCEMENT - UPDATE IN RELATION TO SETTLEMENT OF PROCEEDINGS Legal Proceedings Report	2026-01-30	English
INSIDE INFORMATION ANNOUNCEMENT - UPDATE IN RELATION TO SETTLEMENT OF PROCEEDINGS Legal Proceedings Report	2026-01-29	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO SHARE INCENTIVE SCHEME Share Issue/Capital Change	2026-01-22	English
GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO EQUITY INCENTIVE SCHEME Share Issue/Capital Change	2026-01-16	English
INSIDE INFORMATION ANNOUNCEMENT - SETTLEMENT OF LEGAL PROCEEDINGS Legal Proceedings Report	2026-01-15	English
INSIDE INFORMATION ANNOUNCEMENT IN RELATION TO LEGAL PROCEEDINGS AGAINST A SUBSIDIARY Legal Proceedings Report	2026-01-07	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE IN RELATION TO INVESTIGATIONAL NEW DRUG APPLICATION FOR CBT-009 SUCCESSFULLY SUBMITTED TO CENTER FOR DRUG EVALUATION Regulatory Filings	2026-01-06	English
Next Day Disclosure Return Share Issue/Capital Change	2026-01-04	English
VOLUNTARY ANNOUNCEMENT - VOLUNTARY EXTENSION OF LOCK-UP PERIOD GIVEN BY A CORNERSTONE INVESTOR Regulatory Filings	2026-01-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Regulatory Filings	2026-01-02	English